During the past decade, Monterey Endocrine & Diabetes Institute, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Monterey Endocrine & Diabetes Institute, Inc." are "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Monterey Endocrine & Diabetes Institute, Inc." in a lesser frequency.

Most popular intervention types in "Monterey Endocrine & Diabetes Institute, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (2 trials), "Dulaglutide" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monterey Endocrine & Diabetes Institute, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Monterey Endocrine & Diabetes Institute, Inc.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Monterey Endocrine & Diabetes Institute, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monterey Endocrine & Diabetes Institute, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".